Evidence map›Paper›PMID 41902480›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Proton FLASH Exposure Preserves Gut Commensal Microbiomes and Spares Intestinal Stem Cells.

Rishi Man Chugh, Payel Bhanja, Emily Schueddig, Jufri Setianegara, Yuting Lin, Kenny Guida, Shujah Rehman, Stacey Krepel, Devin Koestler, Ronald C Chen and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rishi Man ChughDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0003-4036-6878
Payel BhanjaDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Emily SchueddigDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
Jufri SetianegaraDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Yuting LinDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Kenny GuidaDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Shujah RehmanDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Stacey KrepelDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Devin KoestlerDepartment of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
Ronald C ChenDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Katherine L CookDepartment of Cancer Biology and Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Subhrajit SahaDepartment of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.ORCID https://orcid.org/0000-0002-7287-073X

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Diane E Mahoney · 2019 to 2026
$21.5M
Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Triterpenoids in mitigation of radiation induced acute or delayed inflammationU01AI170036 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Richard J DiPaolo, John Mark Perry · 2022 to 2026
$3.7M
Progenitor cell based therapy to mitigate radiation induced gastro intestinal syndrome- supplementU01AI138323 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAHA, SUBHRAJIT · 2018 to 2022
$2.8M
NovaSeq X Plus Sequencing SystemS10OD036343 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SMITH, PETER G · 2024 to 2024
$1.1M
NCATS NIH HHS UL1 TR002366NCI NIH HHS P30 CA168524NIAID NIH HHS U01 AI138323NIAID NIH HHS U01 AI170036NICHD NIH HHS U54 HD090216NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM130423NIH HHS S10 OD036343This work was supported by a sponsored Research Agreement from IBA to perform preclinical research on FLASH Proton Radiotherapy (KUMC-IBA collaborative fund) and KUCC CCSG (P30 CA168524).
6 · The paper itself

Abstract

Emerging evidence shows that Proton FLASH radiotherapy can spare normal tissues while maintaining anti-tumor efficacy. However, its impact on intestinal stem cells (ISCs) and the gut microbiome remains unclear. Gut microbiome influences ISC's radiosensitivity. In a mouse model of abdominal irradiation, Proton FLASH exposure exhibited improved survival and less crypt-villus damage compared to Proton Conventional dose rate. Using scRNA-sequencing, we demonstrated that Proton FLASH exposure using pulsed pencil beam scanning spares two distinct ISC populations, Lgr5+ Crypt-based columnar cells (CBCs) and a Ly6a+, Clu+, Areg+, Anxa2+ revival stem cell (revSC) population-by modulating oxidative stress and cell cycle progression. Analysis of α and β-diversity demonstrated that Proton FLASH modulates gut microbiota composition without compromising overall species richness. Notably, Proton FLASH-irradiated mice had higher abundances of Alistipes sp. and Akkermensia sp., both known for protective effects on ISCs and the intestinal mucosa. The role of microbiome in Proton FLASH-mediated sparing effect was further confirmed by fecal microbiota transplantation, where Proton FLASH-donor microbiota demonstrated reduced lethality with protection of crypt villus morphology in recipient mice exposed to Proton Conventional dose rate. Our findings highlight the crucial role of the microbiome in the Proton FLASH-mediated sparing of the mucosal epithelium.

Indexed as

Gastrointestinal MicrobiomeIntestinal MucosaIntestinesProtonsStem CellsAnimalsMiceMice, Inbred C57BLProtonsfecal microbiota transplantgut microbiomeintestinal stem cells (ISCs)proton FLASH/proton CONV irradiationradiation‐induced intestinal injuryrevival stem cells (revSCs)single cell RNA sequencing (scRNA Seq)

Identifiers

PMID41902480
PMCPMC13587989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.